Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Return on Tangible Equity of -229.71% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-19.86M |
|
-- |
|
-- |
|
$20.20M |
|
$-20.20M |
|
$0.35M |
|
$-19.85M |
|
$-19.85M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-20.20M |
|
$-20.20M |
|
3.63M |
|
3.63M |
|
$-5.48 |
|
$-5.48 |
|
| Balance Sheet Financials | |
$15.10M |
|
-- |
|
$0.82M |
|
$15.92M |
|
$7.28M |
|
-- |
|
-- |
|
$7.28M |
|
$8.65M |
|
$8.65M |
|
$8.65M |
|
5.87M |
|
| Cash Flow Statement Financials | |
$-24.59M |
|
-- |
|
$25.56M |
|
$13.48M |
|
$14.44M |
|
$0.96M |
|
$2.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.08 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-229.71% |
|
|
Return on Tangible Equity |
-229.71% |
-124.75% |
|
-229.71% |
|
$1.47 |
|
$-6.78 |
|
$-6.78 |
|